ZENDOZ

Serial Number 98747245
602

Registration Progress

Application Filed
Sep 12, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: ZENDOZ
Previous Owner: Mandara Pharma, Inc.
Classes: 005

Trademark Image

ZENDOZ

Basic Information

Serial Number
98747245
Filing Date
September 12, 2024
Abandonment Date
October 17, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Nov 6, 2025
Classes
005

Rights Holder

Mandara Pharma, Inc.

03
Address
2101 Pearl Street
Boulder, CO 80302

Ownership History

Mandara Pharma, Inc.

Original Applicant
03
Boulder, CO

Legal Representation

Attorney
David S. Kerr

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

16 events
Date Code Type Description Documents
Nov 6, 2025 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Nov 6, 2025 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Jul 16, 2025 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jul 16, 2025 GNFR O FINAL REFUSAL E-MAILED Loading...
Jul 16, 2025 CNFR R FINAL REFUSAL WRITTEN Loading...
Jun 11, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 11, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 11, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 27, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 27, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 27, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 25, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 25, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 13, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 12, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 12, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations containing ingredients solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis

Classification

International Classes
005